v.milanovi

TL3 Regular · Montpellier, FR

Long-standing member. Posts carefully and infrequently, mostly in the practice and analytics categories.

Joined 24 August 2024 · last posted 13h

131 posts, newest first. Showing up to 150.

Composite endpoints and the component doing the work Replied, post #8 · Evidence › Trials · 27 Jul 2026 · 0 likes Adding a data point of agreement rather than a data point.
Molecular mass of semaglutide and why the figure differs between sources Replied, post #111 · Compounds › Semaglutide · 27 Jul 2026 · 0 likes Coming back to post #107, because the follow-up matters more than the original answer. Reporting rather than recommending, on molecular mass of semaglutide. What…
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #56 · Compounds › Repair & healing peptides · 26 Jul 2026 · 0 likes No disagreement from me. Posting only so the question does not look ignored.
Follow-up: How compounding permissions changed when supply normalised Replied, post #77 · Sourcing › Regulatory · 26 Jul 2026 · 0 likes If you can confirm or contradict a position for your own region, please date the answer. An undated regional claim is the least useful thing in this category.
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #46 · Compounds › Retatrutide · 25 Jul 2026 · 3 likes Post #45 is the version of this I will quote in future. One addition. Phase 2 sample sizes are not adequate for safety characterisation of a novel triple agonist. Phase…
Sleep quality changes during weight loss Replied, post #24 · Wellbeing › Sleep · 20 Jul 2026 · 3 likes Where I part company with post #22, and it is a narrow parting. Energy and sleep needs: rapid weight loss increases real metabolic stress. Sleep needs might increase…
Follow-up: Sleep quality changes during weight loss Replied, post #74 · Wellbeing › Sleep · 19 Jul 2026 · 0 likes The arithmetic in post #73 is right; the assumption feeding it is the part to check. Where somebody uses positive airway pressure, changes in weight can change the…
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #92 · Analytics › Impurities & related substances · 19 Jul 2026 · 1 like Coming back to post #90, because the follow-up matters more than the original answer. Racemisation produces a diastereomer that is mass-identical and…
Selection into a registry and what it does to the estimate — a second dataset Replied, post #23 · Evidence › Study critique · 19 Jul 2026 · 0 likes Multiple comparisons without adjustment is a defensible choice when declared in advance and a problem when discovered afterwards. The registry entry settles which…
I joined for one answer and stayed for a year — what changed my mind Replied, post #79 · Start Here › Welcome · 13 Jul 2026 · 27 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #22 · Practice › Dosing & titration · 11 Jul 2026 · 1 like That reframing is the whole thing. The facts I already had.
Athletes in weight-category sports: a different risk calculus Replied, post #19 · Clinical › Special populations · 9 Jul 2026 · 30 likes Post #16 is the version of this I will quote in future. One addition. Where I would push back on the athletes in weight-category sports consensus is the confidence, not…
The anatomy of a question that gets answered within an hour — does this still hold? Replied, post #7 · Start Here › How to Ask · 9 Jul 2026 · 16 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either.
CJC-1295 with and without DAC: what the modification does Replied, post #103 · Compounds › Secretagogues & GH axis · 5 Jul 2026 · 6 likes I read the earlier replies on CJC-1295 twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what was said rather…
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #32 · Documentation › Doc review · 29 Jun 2026 · 0 likes A review date is a commitment rather than a formality, and a shorter cycle for a fast-moving subject is the whole point of setting it deliberately. Caveat: everything…
Insurance and replacement policies, compared Replied, post #28 · Sourcing › Logistics · 18 Jun 2026 · 5 likes Peak periods and public holidays affect this more than any other factor and are entirely predictable in advance.
Blinding yourself: practical methods and their limits Replied, post #34 · Research Methods › N-of-1 designs · 15 Jun 2026 · 12 likes This follows post #33 rather than contradicting it. Blinding: blinding yourself (not knowing which condition you are in) removes expectation bias. This is hard to do…
Carryover and the ghost peak from last week's standard — what changed since Replied, post #31 · Analytics › HPLC & UHPLC · 14 Jun 2026 · 31 likes Confirming post #28 from a second method, which matters more than confirming it from a second person. Mobile-phase preparation is a genuine source of between-laboratory…
[2026 update] Temperature indicator cards: worth asking for? Replied, post #5 · Sourcing › Logistics · 12 Jun 2026 · 0 likes Useful. I have added it to my own notes with the date on it.
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #52 · Outcomes › Progress reports · 29 May 2026 · 3 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
How shortages have affected compounding permissions — does this still hold? Replied, post #7 · Access › Shortages · 29 May 2026 · 0 likes Confirming post #4 from a second method, which matters more than confirming it from a second person. Dose hold versus tapering: if a temporary shortage forces a gap,…
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #62 · Compounds › Repair & healing peptides · 29 May 2026 · 15 likes Stability in solution is the practical constraint. Dry, these keep well; reconstituted, the supplier's own data usually covers a shorter period than people assume. The…
Alcohol: what is documented and what is folklore Replied, post #27 · Practice › Interactions · 25 May 2026 · 0 likes The claim about alcohol upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post says "causes".
Follow-up: Search filters: what is missing Replied, post #110 · Meta › Site feedback · 24 May 2026 · 0 likes Adding the measurement that post #107 says would settle it. Last piece of feedback: the site is much better on a narrow screen than it was six months ago and nobody…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #72 · Compounds › Tirzepatide · 21 May 2026 · 3 likes Two people in this thread mean different things by Tirzepatide and nausea and are disagreeing about the definition while believing they are disagreeing about the facts.…
How much fluid is actually needed, and how you would know Replied, post #6 · marked as the solution · Nutrition & Training › Hydration & electrolytes · 14 May 2026 · 7 likes Fluid intake: baseline needs increase with gastrointestinal effects and exercise. Thirst is not a reliable guide during appetite suppression. Drinking regularly (not…
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #64 · Data & Tools › Datasets · 12 May 2026 · 4 likes Post #60 and I disagree about the size of the effect, not about the direction. The most useful dataset this community could hold is boring: lot, supplier, service,…
A supplier who responds to a discrepancy with silence — what changed since Replied, post #41 · Sourcing › Red flags · 5 May 2026 · 25 likes An unexplained discrepancy that the supplier declined to address is a legitimate thing to record, stated as exactly that and nothing more. That much is documented. The…
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #56 · Practice › Administration · 2 May 2026 · 2 likes Counterpoint on Rotating between abdomen, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the dull…
Converting between mg/mL and units per dose, both directions — the long version Replied, post #83 · Practice › Reconstitution · 23 Apr 2026 · 1 like Marking my place. If it changes for me I will come back and say so.
Converting between mg/mL and units per dose, both directions — the long version Replied, post #62 · Practice › Reconstitution · 21 Apr 2026 · 23 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does.
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #8 · Practice › Reconstitution · 12 Apr 2026 · 16 likes Useful. I have added it to my own notes with the date on it.
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #50 · Practice › Administration · 11 Apr 2026 · 7 likes Narrowing post #47, because the general version has more than one answer. Research-use-only preparations are not supplied with administration instructions because they…
Sample handling between despatch and injection Replied, post #24 · Analytics › Method validation · 7 Apr 2026 · 25 likes The question underneath sample handling between despatch is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write…
Revisiting: Absolute versus relative contraindications Replied, post #60 · Safety › Contraindications · 6 Apr 2026 · 0 likes On post #58 — agreed on the reasoning, with one qualification. Two questions I would want answered before drawing anything from the Absolute versus relative…
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #10 · Devices › Syringes & needles · 5 Apr 2026 · 24 likes Clear enough that I do not think I have a follow-up, which is unusual.
[2026 update] Regional warehouse stock versus direct despatch Replied, post #29 · Sourcing › Logistics · 30 Mar 2026 · 20 likes Everything in post #25 holds. The case it does not cover is the one I have. Regional stock shortens the exposure window more than any packing improvement and is the…
The headache that turns out to be dehydration — the long version Replied, post #15 · Nutrition & Training › Hydration & electrolytes · 30 Mar 2026 · 13 likes That matches what I have seen, for whatever a single anecdote is worth.
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #3 · Analytics › Home & field testing · 28 Mar 2026 · 9 likes Nobody has said the unglamorous part of home kit substitute yet, so: most of the variation is explained by things that are boring to write about and easy to check.
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #26 · Compounds › Repair & healing peptides · 23 Mar 2026 · 11 likes Solubility in this family is generally good, which means a vial that will not go into solution readily is telling you something about the material rather than about the…
A single out-of-range value on an otherwise normal panel Replied, post #25 · Clinical › Bloodwork · 20 Mar 2026 · 7 likes Adding the measurement that post #22 says would settle it. An honest declaration on single out-of-range value: I have a prior here and it is strong enough that you…
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #2 · Compounds › Repair & healing peptides · 18 Mar 2026 · 0 likes Agreed, and I will stop repeating the version of this I had been repeating.
Reused chromatograms across lots: how to spot it — what changed since Replied, post #23 · Analytics › COA interpretation · 12 Mar 2026 · 7 likes Adding a null result on Reused chromatograms across lots. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.
Amylin receptor signalling and satiety — what changed since Replied, post #43 · Pharmacology › Receptor biology · 11 Mar 2026 · 19 likes Receptor desensitisation and internalisation are real phenomena in vitro and their clinical relevance to these compounds is not established. That distinction gets lost…
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #65 · Pharmacology › Pharmacokinetics · 9 Mar 2026 · 13 likes Taking post #62 at face value and following it one step further. A pharmacokinetic model fitted to trial data describes the population studied. Applying it to somebody…
Second pass at: Identical chromatograms across two different lots Replied, post #40 · Sourcing › Red flags · 3 Mar 2026 · 32 likes Building on post #39 rather than restating it. Trying to state the Identical chromatograms position in a way that someone who disagrees would recognise as fair, because…
Revisiting: Language barriers in accessing a prescription abroad Replied, post #136 · Access › International · 28 Feb 2026 · 3 likes I had written a reply contradicting post #133 and deleted it. Here is what survived. Practical experience of Language barriers in accessing, offered as one case with…
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #57 · Analytics › Impurities & related substances · 17 Feb 2026 · 16 likes Post #56 is the version of this I will quote in future. One addition. Freeze-drying itself does not generate impurities in any significant way. Handling before and…
Second pass at: The topic list is dense — is that deliberate? Replied, post #74 · Meta › Site feedback · 17 Feb 2026 · 24 likes Answering the question post #70 raises rather than the one it answers. I would rather this thread reach "we do not know" about topic list than reach a confident answer…
Mass error in ppm: the arithmetic and the caveat Replied, post #69 · Analytics › Mass spectrometry · 14 Feb 2026 · 0 likes Post #65 and I disagree about the size of the effect, not about the direction. Adducts — sodium and potassium especially — shift the observed mass in predictable…
Forced degradation studies: designing one that is informative Replied, post #6 · Analytics › Method validation · 12 Feb 2026 · 22 likes On post #2 — agreed on the reasoning, with one qualification. Why two laboratories may disagree: after validating the same method, they may still report different…
Tag proliferation and whether we should prune — what changed since Replied, post #8 · Meta › Site feedback · 8 Feb 2026 · 6 likes Taking post #7 at face value and following it one step further. Guideline clarity: if the guidelines are unclear or seem to be applied inconsistently, post the specific…
Second pass at: What pooling buys you and what it destroys Replied, post #16 · Evidence › Meta-analyses · 7 Feb 2026 · 25 likes Practical note on pooling buys: write down what you expect before you look. The number of times I have found what I went looking for is higher than chance would allow.
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #81 · Sourcing › Red flags · 7 Feb 2026 · 1 like Keep the two claims separate. "The result on this lot did not match the certificate" is a report that can be checked. "This supplier is dishonest" is an allegation…
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #95 · Compounds › Oral incretins · 3 Feb 2026 · 12 likes Timing consistency matters more for oral dosing than for weekly injection, because absorption depends on the state of the stomach and the state of the stomach varies…
Reference intervals: how they are constructed and why one in twenty flags Replied, post #44 · Clinical › Bloodwork · 1 Feb 2026 · 0 likes Picking up post #41: that is the part I would want checked first. On reference intervals, the part that usually goes wrong is that the question is asked as though it…
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #40 · Documentation › Wiki requests · 16 Jan 2026 · 10 likes Useful. I have added it to my own notes with the date on it.
Aggregates and why a purity assay may miss them entirely Replied, post #8 · Analytics › Impurities & related substances · 14 Dec 2025 · 4 likes Narrowing post #5, because the general version has more than one answer. Relative response factors mean impurities are not detected in proportion to how much of them is…
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #3 · Practice › Storage & stability · 7 Dec 2025 · 0 likes That is a fair summary of where the discussion has got to.
Promotion criteria, and the one that stops most nominations — the long version Replied, post #107 · Documentation › Doc review · 6 Dec 2025 · 5 likes I read post #103 twice before replying, because I had assumed the opposite. The most useful reply I ever got about Promotion criteria was a request to state my units.…
Pen dose counters: what a click does and does not guarantee Replied, post #87 · Devices › Pens & autoinjectors · 18 Nov 2025 · 33 likes Post #86 answers the question as asked. The question underneath it is different. A pen that will not dial to the intended dose is usually telling you the cartridge does…
[2026 update] What steady state means for the decision to escalate Replied, post #72 · Practice › Dosing & titration · 12 Nov 2025 · 4 likes On steady state the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
Documentation that appears only after payment Replied, post #71 · Sourcing › Red flags · 8 Nov 2025 · 1 like Unresponsiveness: a supplier that does not reply to reasonable requests for documentation or clarification is showing you something about how they operate.
Realistic expectations for strength while losing weight quickly Replied, post #32 · Nutrition & Training › Resistance training · 30 Oct 2025 · 0 likes Narrowing post #31, because the general version has more than one answer. The arithmetic on realistic expectations for strength is the easy part and it is where the…
Follow-up: The decimal-point error, and the habit that catches it Replied, post #85 · Practice › Reconstitution · 24 Oct 2025 · 11 likes My understanding of decimal-point error is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep repeating it.
Publishing an inconvenient result: a case study — the long version Replied, post #13 · Sourcing › Independent verification · 19 Oct 2025 · 0 likes I have been on both sides of the Publishing an inconvenient result argument in this category within eighteen months, which should tell you how strong the evidence for…
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #22 · Compounds › Semaglutide · 7 Oct 2025 · 29 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #56 · Practice › Dosing & titration · 25 Sep 2025 · 0 likes What I can speak to on lowest dose is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
Reading an interaction checker output critically Replied, post #8 · Practice › Interactions · 20 Sep 2025 · 0 likes Second this, and I would have said it less carefully.
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #17 · Compounds › Semaglutide · 19 Sep 2025 · 0 likes This follows post #16 rather than contradicting it. Semaglutide's structure is a modified backbone with a C18 diacid attached through a spacer. The acylation is the…
Follow-up: Why appetite effects are mostly central Replied, post #44 · Pharmacology › Receptor biology · 18 Sep 2025 · 6 likes A note on how appetite effects gets discussed rather than on appetite effects itself: the confident posts get the replies and the careful ones get ignored, and the…
High-resolution MS on aggregates and what it can see Replied, post #69 · Analytics › Mass spectrometry · 16 Sep 2025 · 4 likes Agreed on all of that, and I have nothing to add to it.
MHRA statements, read directly Started this topic · Regional › UK & Ireland · 4 Sep 2025 · 47 likes MHRA statements, read directly Writing it up because I had to work it out twice and would rather nobody else did. Asking about MHRA statements directly, because I have…
When a preprint is the best available evidence and we say so Replied, post #115 · Evidence › Preprints · 30 Aug 2025 · 0 likes Taking post #112 at face value and following it one step further. A preprint reporting a null result is more likely to stay a preprint, which biases the published…
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #9 · Documentation › Doc review · 27 Aug 2025 · 0 likes I had written a reply contradicting post #7 and deleted it. Here is what survived. Check the links. Promotion frequently breaks a cross-reference because the source…
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #90 · Compounds › Secretagogues & GH axis · 23 Aug 2025 · 23 likes Thank you for taking the time. That was more work than a reply usually is.
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #67 · Evidence › Journal club · 19 Aug 2025 · 29 likes Confirming post #66 from a second method, which matters more than confirming it from a second person. The most common failure mode is spending fifty minutes on the…
Thyroid function tests during substantial weight change Replied, post #31 · Clinical › Bloodwork · 15 Aug 2025 · 2 likes Post #27 describes the usual case. This is about the unusual one. The documentation on thyroid function tests during substantial is better than this thread and I say…
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #18 · Evidence › Journal club · 14 Aug 2025 · 17 likes The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping.
Insomnia at a dose step: reported experiences Replied, post #4 · Wellbeing › Sleep · 9 Aug 2025 · 0 likes Where the insomnia reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
Why a pen's dose steps are fixed and what that costs you — one year on Replied, post #27 · Devices › Pens & autoinjectors · 29 Jul 2025 · 5 likes Adding a note of thanks rather than an opinion. I did not know most of that.
Publishing an inconvenient result: a case study Replied, post #54 · Sourcing › Independent verification · 23 Jul 2025 · 8 likes Building on post #51 rather than restating it. Offering a way to settle publishing an inconvenient result rather than another opinion about it. Two measurements, taken…
Canadian access and provincial variation — one year on Replied, post #21 · Regional › North America · 23 Jul 2025 · 4 likes The honest answer on Canadian access and provincial variation is that it depends, and the useful part is the list of what it depends on. Four items, in rough order of…
A field-by-field walk through a certificate of analysis Replied, post #80 · Analytics › COA interpretation · 16 Jul 2025 · 7 likes Taking post #79 at face value and following it one step further. Adding a small correction to the field-by-field walk through a certificate summary above rather than a…
Why the timeline is on the right and not the left Replied, post #30 · Meta › Site feedback · 17 Jun 2025 · 0 likes Before the thread moves on from timeline — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n of four and…
Reading an MS report that only gives you a single number Replied, post #107 · Analytics › Mass spectrometry · 14 Jun 2025 · 5 likes Answering the question post #103 raises rather than the one it answers. The honest summary of what a mass result buys you: it narrows the field of what the material…
[2026 update] An appeal that failed, and what I would do differently Replied, post #13 · Access › Insurance & coverage · 7 Jun 2025 · 7 likes Worth stating the null on appeal before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not get one.
Second pass at: Trial registration and comparing the protocol with the paper Replied, post #11 · Evidence › Trials · 3 Jun 2025 · 21 likes The first question about any trial is what it set out to estimate, not what it found. Once the estimand is on the table the rest of the discussion is tractable.
What I would record differently if I started again — the long version Started this topic · Outcomes › Progress reports · 22 May 2025 · 38 likes What I would record differently if I started again — the long version I have a specific reason for asking rather than idle curiosity, and the context is below. Asking…
Pregnancy as an absolute contraindication Replied, post #18 · Safety › Contraindications · 17 May 2025 · 4 likes Nothing here is medical advice, and a contraindication question is one where the cost of a wrong forum answer is high. Speaking for myself and not for anyone else who…
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #31 · Evidence › Trials · 16 May 2025 · 22 likes An open-label trial is not worthless and its subjective endpoints deserve more scepticism than its objective ones. That is a graded judgement rather than a verdict.…
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #116 · Compounds › Cagrilintide & amylin analogues · 16 May 2025 · 8 likes Post #115 is right about the mechanism and I think understates the practical bit. Reconstitution at higher concentrations is worth avoiding for aggregation-prone…
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #40 · Practice › Reconstitution · 20 Apr 2025 · 23 likes Research-use-only material reconstituted at home is not a compounded sterile preparation and nothing about the procedure makes it one. Members describing what they do…
Coverage for the indication versus for the drug Replied, post #32 · Access › Insurance & coverage · 17 Apr 2025 · 1 like Understood. Thank you for being specific about the limits of it.
A well-designed study with a badly written abstract Replied, post #20 · Evidence › Study critique · 12 Apr 2025 · 0 likes Narrowing post #18, because the general version has more than one answer. I changed my mind about well-designed study after someone here asked me for the source and I…
Reading a chromatogram someone posted without axes Replied, post #19 · Analytics › HPLC & UHPLC · 8 Apr 2025 · 0 likes On reading a chromatogram the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
Research-use-only labelling: what it means and what it does not — the long version Replied, post #122 · Sourcing › Regulatory · 6 Apr 2025 · 16 likes I would keep Research-use-only labelling and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and…
Why cagrilintide alone is discussed so much less than in combination Replied, post #39 · Compounds › Cagrilintide & amylin analogues · 27 Mar 2025 · 6 likes Cagrilintide molecular characteristics: it is a synthetic amylin analogue, substituted to prevent the amyloidogenicity of human amylin. The sequence is short and…
One lot is one lot: when a report becomes a pattern — the long version Replied, post #108 · Sourcing › Vendor reports · 18 Mar 2025 · 0 likes Lot matching: confirm the lot number on the certificate matches the lot number on the vial. A result from a different lot is not evidence about your vial. Stating my…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #63 · Sourcing › Regulatory · 2 Mar 2025 · 6 likes Where a claim about legality is made here, the useful follow-up is which instrument it rests on. Most such claims turn out to rest on a forum post. Not a strong…
Revisiting: Aggregate verification data across the directory, with caveats Replied, post #21 · Sourcing › Independent verification · 2 Mar 2025 · 0 likes I read post #19 twice before replying, because I had assumed the opposite. I would put moderate confidence on the mainstream reading of Aggregate verification data and…
Consistent declarations and why they matter more than clever ones Replied, post #110 · Sourcing › Logistics · 2 Mar 2025 · 0 likes Practical note on consistent declarations: write down what you expect before you look. The number of times I have found what I went looking for is higher than chance…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #27 · Sourcing › Regulatory · 28 Feb 2025 · 3 likes The reason pharmaceutical compounding rules is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for…
Consistent declarations and why they matter more than clever ones Replied, post #73 · Sourcing › Logistics · 23 Feb 2025 · 0 likes The failure mode on consistent declarations is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple to…
Why mass spectrometry cannot tell you about an epimer Replied, post #66 · Analytics › Mass spectrometry · 22 Feb 2025 · 16 likes Agreed on all of that, and I have nothing to add to it.
Protein density versus volume when you cannot eat much Replied, post #99 · Nutrition & Training › Protein & intake · 9 Feb 2025 · 0 likes What tends to work is front-loading the day, prioritising density over volume, and treating it as a solvable problem rather than an inconvenience. For what it is worth,…
A promotion I argued against, and why I lost Replied, post #82 · Documentation › Doc review · 1 Feb 2025 · 0 likes The most useful review comment names a sentence and says what is wrong with it. General approval and general concern are both hard to act on. If it helps: the failure…
Review: a draft on reconstitution arithmetic, with objections Replied, post #6 · Documentation › Doc review · 29 Jan 2025 · 0 likes Review of promoted topics: when a topic is nominated for promotion to a maintained documentation page, the draft is posted here. Community review happens before…
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #69 · Data & Tools › Calculators · 29 Jan 2025 · 0 likes Post #67 put the caveat in the right place and I want to underline it. A saved calculation is worth more than a remembered one. Write down the inputs alongside the…
Reading a supplementary appendix and finding the interesting part Replied, post #77 · Evidence › Trials · 26 Jan 2025 · 5 likes Adding a small correction to the reading a supplementary appendix summary above rather than a disagreement with it. The substance holds; one of the figures is out by a…
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #93 · Evidence › Journal club · 15 Jan 2025 · 3 likes SURPASS-2 has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #29 · Compounds › Secretagogues & GH axis · 13 Jan 2025 · 19 likes The arithmetic in post #28 is right; the assumption feeding it is the part to check. Reconstitution volumes in this family are often small enough that dead volume in…
Follow-up: Individual participant data versus aggregate data Replied, post #63 · Evidence › Meta-analyses · 10 Jan 2025 · 0 likes Filing a mild objection to the consensus on Individual participant data versus aggregate. Mild because I might be wrong; an objection because nobody has addressed the…
What we do not know about retatrutide, listed explicitly Replied, post #47 · Compounds › Retatrutide · 7 Jan 2025 · 4 likes Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is not established is whether the tolerability profile differs from…
Coming back to: Reading a meta-analysis you disagree with, fairly Replied, post #15 · Evidence › Meta-analyses · 6 Jan 2025 · 0 likes Fair, and the limits you put on it are the part I will remember.
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #144 · Compounds › Oral incretins · 29 Dec 2024 · 8 likes Helpful, and easy to find again, which is half of what a good reply is.
Body image changing more slowly than the body Replied, post #100 · Wellbeing › Mental health · 22 Dec 2024 · 0 likes Everything in post #98 holds. The case it does not cover is the one I have. Support and community: some people process weight change through community (online or…
What changed in 2026, by region Replied, post #30 · Access › International · 19 Dec 2024 · 7 likes Everything in post #28 holds. The case it does not cover is the one I have. Regulatory position dates: a regulatory position is only current as of when it was written.…
Follow-up: Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #5 · Compounds › Semaglutide · 6 Dec 2024 · 11 likes The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #66 · Compounds › Tirzepatide · 2 Dec 2024 · 0 likes Seconded. It reads as careful rather than confident, which is the right register.
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #27 · Practice › Reconstitution · 27 Nov 2024 · 0 likes No notes. Posting so the count is not one.
[2026 update] Step therapy requirements and how to satisfy them Replied, post #31 · Access › Insurance & coverage · 18 Nov 2024 · 3 likes Building on post #29 rather than restating it. Genuine question rather than a rhetorical one: has anyone here actually observed Step therapy requirements, as opposed to…
EMA product information as a primary source — does this still hold? Replied, post #104 · Regional › European Union · 17 Nov 2024 · 2 likes EMA product information is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
EMA product information as a primary source — does this still hold? Replied, post #100 · Regional › European Union · 17 Nov 2024 · 3 likes I disagree with the framing of EMA product information above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so it can…
Why "any advice?" is the least effective ending for a post Replied, post #30 · Start Here › How to Ask · 12 Nov 2024 · 0 likes Avoid "any advice?" at the end. It is so generic that people do not know which part of the post it refers to. Pick the specific part and ask that specific question…
When to suspect the method rather than the sample Replied, post #24 · Analytics › Method validation · 16 Oct 2024 · 0 likes The limit of quantitation determines what the impurity table can honestly contain. Peaks below it can be reported as detected and cannot be reported as a number. The…
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #34 · Compounds › Other compounds · 5 Oct 2024 · 11 likes Distinguishing three things in the Melanocortin agonists discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the…
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #11 · Clinical › Comorbidities · 30 Sep 2024 · 3 likes The practical value of this subcategory is helping somebody frame the question they take to an appointment, and that is worth being explicit about. Filing this under…
Tracking a preprint to publication: a worked example — the long version Replied, post #40 · Evidence › Preprints · 21 Sep 2024 · 12 likes Say it is a preprint in the first line rather than the last. Everything downstream depends on that status and readers arriving from search will not scroll for it.
Chronic kidney disease and the FLOW result Replied, post #11 · Clinical › Comorbidities · 13 Aug 2024 · 10 likes Cardiovascular disease: several compounds have cardiovascular outcome trials. SELECT was in people without diabetes; SUSTAIN 6 was in high-risk diabetes. Absolute…
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #46 · Practice › Dosing & titration · 8 Jul 2024 · 0 likes I read post #42 twice before replying, because I had assumed the opposite. Reaching a dose and staying there for a year: the question of whether a stable dose remains…